HEALTH RESULTS-BASED FINANCING PROJECT IDA GRANT NUMBER TF01 3310 IMPLEMENTED BY RESULT-BASED FINANCING SECRETARIAT UNIT UNDER THE MINISTRY OF HEALTH OF THE KYRGYZ REPUBLIC SPECIAL PURPOSE PROJECT FINANCIAL STATEMENTS AND INDEPENDENT AUDITOR'S REPORT For the year ended 31 December 2017 BISHKEK June 2018 HEALTH RESULTS-BASED FINANCING PROJECT IDA GRANT NUMBER TF013310 TABLE OF CONTENTS Page STATEMENT OF MANAGEMENT'S RESPONSIBILITIES FOR THE PREPARATION AND PRESENTATION OF THE SPECIAL PURPOSE FINANCIAL STATEMENTS 3 INDEPENDENT AUDITOR'S REPORT 4-5 SPECIAL PURPOSE FINANCIAL STATEMENTS For the year ended 31 December 2017: Statement of cash receipts and payments 6 Statement of expenditures per components 7 Notes to the special purpose financial statements 8-13 ANNEX 1. RECONCILIATION BETWEEN THE AMOUNTS SUBMITTED BY RBF SECRETARIAT AND DISBURSED BY THE WORLD BANK 14 2 STATEMENT OF MANAGEMENT'S RESPONSIBILITIES FOR THE PREPARATION AND PRESENTATION OF THE SPECIAL PURPOSE FINANCIAL STATEMENTS The management of the RBF Secretariat under the Ministry of Health of Kyrgyz Republic (hereafter: RBF Secretariat) is responsible for the preparation of the special purpose financial statements of Health Results-Based Financing Project (hereafter: the Project) financed by IDA Grant Number TF013310 that present fairly the Project's cash receipts and payments, expenditures per components for the year ended 31 December 2017, in compliance with the International Public Sector Accounting Standard "Financial Reporting under the Cash Basis of Accounting" (IPSAS-Cash Basis) issued by the International Public Sector Accounting Standards Board (IPSASB) within the International Federation of Accountants (IFAC) and the Financial Management Manual for World Bank Financed Investment Operations (WB Guidelines). In preparing the special purpose project financial statements, PIU's management is responsible for: * Property selecting and applying accounting policies; * Presenting information, including accounting policies, in a manner that provides relevant, reliable, comparable and understandable information; * Providing additional required disclosures for the year ended 31 December 2017. PIU's Management is also responsible for: * Designing, implementing and maintaining an effective and sound system of internal controls, throughout the Project; * Maintaining adequate accounting records that are sufficient to show and explain the Project's transactions, and which enable them to ensure that the special purpose financial statements of the Project comply with IPSAS - Cash Basis and the WB Guidelines; * Taking such steps that are reasonably available to them to safeguard the assets of the Project and to affirm that funds received have been used in accordance with the IDA Grant Number TF013310 dated 30 December 2013, and World Bank related guidelines, with due attention to economy and efficiency, and only for the purposes for which the financing was provided; and * Preventing and detecting fraud and other errors. The special purpose financial statemen for the year ended 31 December 2017 were authorized for issue on 12 June 2018 by RBF Secret t un the Ministry of Health of Kyrgyz Republic. ___'Z aev Kosmosbek Mi ster of Health of the Kyrgyz Republic Oskombaeva Kara Esengul Kanatbek Director Finance Manager RBF Secretariat RBF Secretariat 3 Tel: +37410 528899 10 V. Sargsyan str., E-mail: bdo@bdoarmenia.am Office 114, www.bdoarmenia.am Yerevan, Armenia INDEPENDENT AUDITOR'S REPORT To the Ministry of Health of the Kyrgyz Republic Opinion We have audited the special purpose financial statements of "Health Results-Based Financing Project" ("Project") financed by Financing Agreement IDA Grant Number TF013310 dated 30 December 2013 ("Grant Agreement"), and implemented by RBF Secretariat under the Ministry of Health of Kyrgyz Republic ("RBF Secretariat"), which comprise the statement of cash receipts and payments and the statement of expenditures per components for the year ended 31 December 2017, and notes to the special purpose financial statements, including a summary of significant accounting policies. In our opinion, 1. the accompanying financial statements present fairly, in all material respects, the cash flows for the year ended 31 December 2017 in accordance with International Public Sector Accounting Standard: Financial Reporting Under the Cash Basis of Accounting, (IPSAS-Cash Basis); 2. funds have been used in accordance with the conditions of the Grant Agreement concluded between the International Development Association (IDA) and the Kyrgyz Republic, and WB Guidelines, with due attention to economy and efficiency, and only for the purposes for which the financing was provided; 3. supporting documents, records and accounts have been maintained to support claims for reimbursement of expenditures incurred. Expenditures included in the withdrawal applications and reimbursed against are eligible for financing under the Grant Agreement; Interim Unaudited Financial Statements (IFSs) issued by RBF Secretariat during the reporting year are in agreement with the underlying books of account; 4. The Designated account used has been maintained in accordance with the provision of the Grant Agreement, and World Bank related guidelines; 5. Goods and Services financed have been procured in accordance with the Grant Agreement and World Bank related guidelines; 6. Financial covenants in the Part B of the Section II of the Schedule 2 of the Grant Agreement were complied. Basis for Opinion We conducted our audit in accordance with International Standards on Auditing (ISAs) as issued by International Auditing and Assurance Standards Board (IAASB) of the International Federation of Accountants (IFAC). Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Project and of the RBF Secretariat in accordance with the International Ethics Standards Board for Accountants' Code of Ethics for Professional Accountants (IESBA Code), and we have fulfilled our other ethical requirements in accordance with IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Emphasis of matter - low disbursement level Without qualifying our opinion, we draw your attention to Note 7 of these special purpose financial statements disclosing that though the Project closing date is extended from 30 June 2017 to 31 December 2018, cumulative expenditure accounts to only 59% of the Project total budget as at 31 December 2017; and the measures taken by the management of the RBF Secretariat. Emphasis of Matter- Cash Basis of Accounting We draw attention to Note 2 to the financial statements, which describes that financial statements are prepared in accordance with cash basis framework, as a result, they may not be suitable for another purposes. Our opinion is not modified in respect of this matter. 8DO Armenia cjsc, is a member of BDO international Limited, a UK company limited by guarantee, and forms part of the internationaL BDO network of independent member firms. Responsibilities of the Management for the Financial Statements Management of the RBF Secretariat is responsible for the preparation and fair presentation of the special purpose financial statements in accordance with IPSAS-Cash Basis issued by the International Public Sector Accounting Standards Board (IPSASB) of the IFAC and Financial Management Manual for World Bank Financed Investment Operations ("WB Guidelines"), and for such internal control as management determines is necessary to enable the preparation of special purpose financial statements that are free from material misstatement, whether due to fraud or error. Auditor's Responsibility for the Audit of the Special Purpose Financial Statements Our objectives are to obtain reasonable assurance about whether the special purpose financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is high level of assurance, but is not a guaranty that an audit conducted in accordance with ISAs will always detect a material misstatement when it exists. Misstatements arise from fraud and error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these special purpose financial statements. As part of an audit in accordance with ISAs, we exercise professional judgement and maintain professional skepticism throughout the audit. We also: * Identify and assess the risks of material misstatement of the special purpose financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. * Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the internal control. * Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management. * Evaluate the overall presentation, structure and content of the special purpose financial statements, including the disclosures, and whether the special purpose financial statements represent the underlying transactions and events in a manner that achieves fair presentation. We communicate with management regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. "BDO Armenia" CJSC 12 June 2018 bII o 4 hachatryan, FCCA A-6 'agement Partner "IWO ARKENIA" rl 14 01569792 0 IBDO v а� и R 1] _ о и с � h м г°V й � � °O `r r! iГ. > N v •о .� _ го�� � 00, о о Ё °д -- � г` а.+ й й м 'С_ С � � � а у i у Ом0 � N а+ л � � v .о С � r'� р �С ь�'.. � +-о+ � � b а v ш n CL 7 и_ а� -- •и � � й а � о �, n >_ й v v � � м'" � Г "" '* а � _� а�'i � � о � Г � с т и м оип - v _ � � г� о о � и д м +.+ ' а cs �о � р д � с д � R м �о � b G7 ++ о о ал N N с ro` � а Ф а �С гСб +�+ � �- С � � й b �СЙ � �' �V О О О� О О 0/ С_ � (б aL.+ -- b^ �� � о й � W 1L GC с 0 � � р °о � о�о й� й y.r ОЛ b д g� и ��O � ^ с 7 � � �of1 _ 7 м а д 7 V О � а о �' N д�' � й .�о с0 � .р0 j с'"б __ л р � � и 1� V� О. а.+ с � о°O •ио N м й � С � и р � О. .О U � �- N N � Ш � ' д а v ' __ � о и Ш т � � � v �, о � -_� � а0 ^ � � . г а � v с >, � д д � � � ro .� � с on и __ р 1� � о р, и � �а О С� Е С �`i=. а . • �N-� �и� vo й� Cr �� го а� и С � _ ^о о т а'о � � .ос с �vo а�� и.. Е а� О а й '� - с� � Еа � vапи �- шv С м +.и+ U ' бго. L ��� � с а=.+ LLo R+Фj р �� �.� F м й� �С LL •v �.С м и о и� С рр а� • ' �~ � М С м с�+ С� yZj и .и й � а`> �s1�3 й ° d�ro °� а�с Й � аоп о�'л= т� и Ш о � ~ >>, а j fui � b �' � Сб 'С3 -� и� ^ iб ►-. и й У г'�"'0 р, � С N� CJ С И t� � v д G1 С+�' G С� Ор с д О 7 г С�� г � � G С> с v v � й > а.р+ •- о го Е и,F, �, гв т ш г г �ц:� ' й оп о о Ф N N и с го �_ � л уи О `� �+ � W� а�, о� а й � � й у.а,.,' b R . ы� � � гсд t; и Ф с О 7 - �` �s � а �� а д_= 5с°� �° а а о �'л � с L й � а ��� р о о р ��� N а О О й� Ф N= � с. -- = 0 й'О Q ь- и_ F- а... а.� О 1- F' р С� � Н �• о 1\ й м .о � � � � й �- � Со м � N '� р �" м" м � � и м и > N о�о �р й у � гио ;:� � ,� м с .д � 7 а+ � й � с м С! U +' � и '�° ii - R_f � О •� � 7 ' � У � О �f �о � � �t ; ^ л � W м О � N С_ yi ер" v м" �„� м � � �. с й .и�.о v м � о ° s '� .� �. „ а л д � v а +.+ - сб v а � ^ � N О� 1л �О v v ^ � � ui о" �л � -_ > И р Г `с 1^� м � ер а�0 и а+ � N N V' й 7 . �О � е- ^ OQ � М 7 � и м а о _. � р � С С гс0 о�л � д � Й О N ар0 � N й р � j Ф � О � рр а0 � а0 р .С] _.- с м "'' ,д, � n' N N о, � *'' д GJ С t' N N N � L � n О b Q) ++ � ь. __ � гд С � го � г0 а.�+ й � го о > � � го >. �ŭaui 'й ш � � � й � й v v й С� и � t _ О У Ф N о� `с с� � ^ и м � С т С_ р [� •�•�-, � й v м � � ао � W 1i в: "' оп �_ и и � � с .,--, с � "'� о '6n ._ ��ю Q д � 1и0 Й С! Q а " � _ оп � `° о�о ^ � � о � � ,,_, о. �•- ^ ^ а с` м " н .д' v v �л" оо <-L° � ro �о � ^ ''� N а� са � л � � и о; •го � , � ш L � а � . -- � и и �- �7 0 ьи.. С_ L � � � а�.+ И . +� G1 у 2� �С F+ Й � С � L _ '" �v ид�5о о'т О .'-' �'�° о= уЕ�а а' ол t д .ь+ 1� м и � й� = а д'сол с гСс L д �'° .. � О С G� Ф Ci +и'=' � и и � д С� rt й С � � л -'О р„ 1� cci G�i � с c�v R`� ц' � а гса ° � а й с" Е с L У � о N^. R р о ш° с й� о '° и b с � � о С ��� а v а� Фс�� а�сго с v ��D v�v о'D Е м-w ��•�У г� sv 'с� о � л� °� v ш �о о о со v с С - �� wEa АзN ;;� ��W� �с°оЕ � vv с � i�. N и д� 0 v v .>`t С г�о г�о й� avгf w y,s jL,O �0� � о� � и Ф г0 а N а� lJ гб М и а� v..c с а rovro vc � шго 'С LL. .,�. .С с ro v га Ф � и с � v- •г, га � � _. й� "�s j� Ё о ro> с€ ,r,, � С ai+° v° о Е оо а� � д �-о 3 о� ап� �° с+л�+��' G� о�с � � а�'п� т,р CL Ф о v- с.✓ с�t G7 '� •^ DП '^ ОП й с о fб у, � � и й Е a�i с й °° й�� а 'с ао с ro с•5.�,_, У b а д � 'S о�� ` - йг � с`в т у о�^ о= nг°"а � �ru � ас aL aaci > .i° о о з Ё � С � л,и� С а д и С й b� й� го Е й Е � й� �о `. � N� с го - ,с ` � ш� а � с гд л��'й e�i � Е п':, ,�' .д � �°- J д� й с о `6 � а Е с vY _(9 ��а Е уΡRPго ого уΡ� SO Е �'i � s� L i L �+.+ ь.- L. ° W, N О N а.+ N.� , � ��� -) � F-- RJ -- др � oQ U аш аг°.а`� � Ор� �� �о _- V]l.L`, Health Results-Based Financing Project IDA Grant Number TF01 3310 Notes to the special purpose financial statements For the year ended 31 December 2017 1. General information 1. 1. The Project The Grant Agreement IDA Grant TF013310 was concluded on 30 December 2013 between the Kyrgyz Republic and the International Development Association (IDA), according to which IDA, acting as administrator of grant funds provided by the Mutti-Donor Trust Fund for Health Results Innovation, provided financing in the amount of 11,000,000 United States dollars (USD) for the implementation of "Health Results-Based Financing Project" (the Project). The Project became effective on 29 July 2014. The Closing date of the IDA Grant Number TF01 3310 is set 31 December 2018 (as updated). The Grace Period for submitting withdrawal application for expenditures incurred before the Closing date is four months following the Closing dates: 30 April 2019 (as updated). 1.2. The Project objectives The objectives of the Project are: 1. to pilot performance-based payments and enhanced supervision for quality of maternal and neonatal care in randomly selected rayon hospitals; and 2. to strengthen the Recipient's and healthcare providers' capacity in performance- based contracting and monitoring and evaluating for results. The Project consists of the following parts: Part 1: Pilot Performance-Based Payments and Enhanced Supervision for Quality of Health Care (a) Conducting a randomized controlled trial at the rayon hospital level (b) Supporting Incremental Operating Costs of MHIF to manage performance- based contracts with health facilities. Part 2: Strengthen the Government's and Health Care Providers' Capacity in Performance- Based Payment Reform and Monitoring and Evaluation for Results (a) Improving the capacity of MOH and MHIF through provision of technical assistance, (b) Improving the capacity of Participating Providers through provision of technical assistance and training, (c) Supporting Project coordination, implementation, management and monitoring through the provision of training, goods, and financing of MOH Incremental Operating Costs. 1.3. The Project Budget and Financing The Project is 100% financed (inclusive of taxes) by IDA Grant Number TF013310. Category IDA Grant Number Total TF013310 USD USD (1) Incentive Payments to Participating Providers under Part 1 of the Project 8,832,230. 8,832,230 (2) Goods, Consultant Services, Incremental Operating Costs, and Training 2,167,770 2,167,770 Total _11,000,000 1,000,000 8 Health Results-Based Financing Project IDA Grant Number TF01 3310 Notes to the special purpose financial statements For the year ended 31 December 2017 1.4. Project Implementation The Ministry of Health of the Republic of Kyrgyzstan (MOH) established the RBF Secretariat to ensure the project implementation with the following functions: (i) providing day-to-day implementation and management of the Project, including financial management, procurement, and fiduciary audits for service providers; (ii) participating as observers during peer verification; (iii) assessing the validity of reported data to ensure accuracy and reduce the ikelihood of misreporting; and (iv) conducting counter-verification on a semi-annual basis. For the project purposes MOH has allocated 64 health facilities for 3 groups since commencement of the Project: * Group 1 (21 facilities + pilot Chui hospital): use of an enhanced supervision scheme that utilizes a Balanced Scorecard (BSC) to assess quality of care together with a performance-based payment made against the level of facility performance achieved on a quarterly basis; * Group 2 (21 facilities): use of only the enhanced supervision scheme that utilizes the BSC without performance-based payments. * Group 3 (21 facilities): a control group of hospitals, without any involvement under the Project. In 2017, the Ministry of Health and WB came to an agreement to commence result based financing to medical centers under Group 2 and 3 since quarter 2, 2017. These 42 hospitals periodically receive intensive monitoring / enhanced review using a balanced system of indicators with a payout of no more than 5%. In addition, the project included Primary Health Care (PHC) health organizations. Two pilot Centers for Family Medicine in the North and South of the country were selected for the development and testing of RBF tools. Currently, the RBF Secretariat, together with the MHIF Foundation, is carrying out preparatory work for the implementation of the RBF PHC across the country with a share of government funding. RBF Secretariat address is: room 6, Togolok Moldo Street 1, Bishkek, Kyrgyz Republic. 9 Health Results-Based Financing Project IDA Grant Number TF01 3310 Notes to the special purpose financial statements For the year ended 31 December 2017 2. Summary of significant accounting policies 2.1. Preparation and presentation of financial statements The special purpose financial statements are prepared in accordance with the International Public Sector Accounting Standard: Financial Reporting Under the Cash Basis of Accounting (IPSAS-Cash Basis), issued by the International Public Sector Accounting Standards Board (IPSASB) within the International Federation of Accountants (IFAC), and presented in accordance with Financial Management Manual for World Bank Financed Investment Operations (March 2010): RM 3 - Financial Reporting and Auditing. The principal accounting policies applied in the preparation of these special purpose financial statements are set out below. These policies have been consistently applied to all the periods presented. 2.2 Cash basis of accounting Project financing is recognised as a source of project funds when the cash is received. Project expenditures are recognised as a use of project funds when the payments are made. 2.3 Reporting currency The reporting currency of these special purpose financial statements is United States dollars (USD). The expenditures made in local currency, Kyrgyz Som (KGS), are translated into USD based at the exchange rate prevailing at the date of the transaction. The effect of exchange rate changes on cash held on foreign currency is reported as separate line item in the statement of cash receipts and payments. The exchange rate defined by the National Bank of the Kyrgyz Republic is as follows: 31 December 2016: USD 1 = 69.2301 KGS. 31 December 2017: USD 1 = 68.8395 KGS 2.4. Taxes Taxes are paid in accordance with the tax regulations of the Kyrgyz Republic. 2.5. Budget Expenditure budget is created based on actual accumulated expenditures for the last period plus the updated procurement plans for the Reporting year. 10 Health Results-Based Financing Project IDA Grant Number TF013310 Notes to the special purpose financial statements For the year ended 31 December 2017 3. Summary of Summary Reports and SOEs Payment categories Total Withdrawal Withdrawal application application (1) Incentive Payments to (2) Goods, Consultant No value date Participating Providers Services, Incremental under Part 1 of the Operating Costs, and Project Training 16 19.Apr.2017 564,214.28 81,737.08 645,951.36 17 25.Jul.2017 764,876.43 107,632.62 872,509.05 19 07.Dec.2017 480,007.85 66,868.51 546,876.36 Total 1,809,098.56 256,238.21 2,065,336.77 4. Statement of Designated Account Bank account number 1013350200002170 Bank National Bank of The Kyrgyz Republic Bank location 101 T. Umutative Street, Bishkek, Kyrgyz Republic Currency USD IDA Grant No. TF01 3310 Year ended 31.Dec.2017 1. Opening balance as at 1.Jan.2017 514,049 2. Add: opening discrepancy - 3. WB advance/replenishment 2,065,337 4. Less: Refund to WB from DA - 5. Present outstanding amount advanced to DA 2,579,386 6. DA closing balance as at 31.Dec.2017 655,460 7. Add: Amount of eligible expenditures paid 1,923,926 8. Less: interest earned (if credited to DA) - 9. Total advance accounted for 2,579,386 10. Closing discrepancy (5)-(9) - 11 Health Results-Based Financing Project IDA Grant Number TF013310 Notes to the special purpose financial statements For the year ended 31 December 2017 5. Statement of Financial Position The Statement of Financial Position discloses assets, liabilities and net assets of the Projects as at reporting date. It is prepared in accrual basis that is transactions are recognized when they occur (and not only when cash is received or paid). Note 31 Dec 2017 31 Dec 2016 USD USD ASSETS Cash 6 655,460 514,049 Prepayments (operating costs) - 6,037 Total assets 655,460 520,086 LIABILITIES Payables - - Total liabilities - - NET ASSETS Cumulative income IDA Grant No. TF013310 8 7,098,970 5,018,813 7,098,970 5,018,813 Cumulative expenses Project expenses 7 6,443,510 4,498,728 6,443,510 4,498,728 Total net assets 655,460 520,086 6. Cash Underlying 31 Dec 2017 31 Dec 2016 Currency USD USD Designated Account (IDA Grant TF013310) USD 655,460 514,049 655,460 514,049 12 Health Results-Based Financing Project IDA Grant Number TF013310 Notes to the special purpose financial statements For the year ended 31 December 2017 7. Project Expenditures budget execution Cumulative Expenditures Total Project as at 31 Dec 2017 Budget Progress (a) Category USD USD % (1) Incentive Payments to Participating Providers under Part 1 of the Project 5,486,449 8,832,230 62% (2) Goods, Consultant Services, Incremental Operating Costs, and Training 957,061 2,167,770 44% Total 6,443,510 11,000,000 59% (a) The Grant Agreement IDA Grant TF013310 was concluded on 30 Dec 2013 and became effective on 29 July 2014. The incentive payments to selected medical centers commenced from Dec 2014. On 23 June 2017 the WB extended the Project closing date from 30 June 2017 to 31 December 2018. Incentive disbursements to Third group of 42 medical centers, as agreed with WB, commenced from Dec 2017. However, only 59% of the total budget is implemented as of 31 Dec 2017. Low rate of implementation of the Project is mainly due to significant appreciation (about 60%) of the USD against KGS between financing period and budgeted rate. Related to Category 1, the disbursement for 2nd quarter and 4th quarter for 2017 in the total amount of USD 839,540 (10% of total budget for Category 1), were done only in 2018 due to some organizational issues. Total unused amount of Category 1 as of today is USD 2,506,241, of which USD 490,000 will be paid in June 2018 based on the results of the evaluation of health organizations for the 1st quarter of 2018. The remaining will be disbursed in the second half of 2018, as the number of health organizations receiving RBF funds increases, and 3rd quarterly reviews are yet to be conducted. In addition, in 2018, the Procurement Plan includes new items for the procurement of goods necessary for the further institutionalization of the RBF mechanism. Procurement processes for them have already begun or are under negotiation in the World Bank. 8. Financing IDA Grant No TF013310 Reporting Cumulative as year at 31 Dec 2017 USD USD Advances/ (advance recovery) - 1,160,000 Direct Payments 14,820 104,970 SOE and Summary Report 2,065,337 5,834,000 Total 2,080,157 7,098,970 Total financing budget 11,000,000 Percentage of finance provided as at 31 Dec 2017 65% 9. Events after the reporting date The application N 21, that consists expenditures relating to the reporting year in the amount of 504,539.67 USD was submitted to WB on 15 March 2018 and approved on 16 March 2018. 13 Health Results-Based Financing Project IDA Grant Number TF01 3310 ANNEX 1. RECONCILIATION BETWEEN THE AMOUNTS SUBMITTED BY THE RBF SECRETARIAT AND DISBURSED BY THE WORLD BANK For the year ended 31 December 2017 (Amounts are shown in US dollars) IDA Grant TFO 13310 Expenditure Category Appl. RBF Secretariat WB Difference (1) Incentive Payments to 16 564,214.28 564,214.28 - Participating Providers under Part 17 764,876.43 764,876.43 - 1 of the Project 19 480,007.85 480,007.85 - 1,809,098.56 1,809,098.56 (2) Goods, Consultant Services, 16 81,737.08 81,737.08 - Incremental Operating Costs, and Training 17 107,632.62 107,632.62 - 19 66,868.51 66,868.51 - 18 DP 14,820.00 14,820.00 - 271,058.21 271,058.21 Total 2,080,156.77 2,080,156.77 14